Read more

November 08, 2019
3 min watch
Save

VIDEO: Eyevance co-founder highlights recent activities

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

ORLANDO, Fla. – Eyevance Pharmaceuticals has completed seven transactions over the last 2 years that have resulted in the company bringing 10 products to the market, Jerry St. Peter, CEO and co-founder, said.

He detailed the products, from “revenue-generating, everyday eye drops” that clinicians use in practice to innovative products designed for unmet medical needs and rare conditions.

Disclosure: St. Peter is employed by Eyevance.